Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optina in diabetic macular edema
NCT02002403Phase 2Completed
- Sponsor
- Unity Health Toronto
- Start
- Jan 2011
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of danazol in diabetic macular edema (DME), sponsored by Unity Health Toronto. Started Jan 2011; status: completed.
02
Drugs
danazol
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02002403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002403.